We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$144B
AUM Growth
+$2.8B
(+2%)
Cap. Flow
-$5.9B
Cap. Flow
% of AUM
-4.09%
Top 10 Holdings %
Top 10 Hldgs %
29.72%
Holding
347
New
10
Increased
58
Reduced
237
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$187M |
| 2 |
Intel
INTC
|
+$174M |
| 3 |
Aurora
AUR
|
+$114M |
| 4 |
Alibaba
BABA
|
+$86.2M |
| 5 |
Pulmonx
LUNG
|
+$72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$763M |
| 2 |
Tesla
TSLA
|
+$478M |
| 3 |
Adobe
ADBE
|
+$327M |
| 4 |
Microsoft
MSFT
|
+$319M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Healthcare | 26% |
| 3 | Industrials | 11.45% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Financials | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$12.4B
| $1.57B | 1.09% |
17,804,780
-132,550
| -0.7% | -$10.9M |
|
27
Bank of America
BAC
$442B
| $1.5B | 1.04% |
33,730,141
-3,485,780
| -9% | -$159M |
|
28
Baidu
BIDU
$37.2B
| $1.42B | 0.99% |
9,569,669
+535
| +0% | +$83.5K |
|
|
29
Bristol-Myers Squibb
BMY
$132B
| $1.38B | 0.95% |
22,114,455
+3,195,680
| +17% | +$187M |
|
30
Intuit
INTU
$89B
| $1.33B | 0.92% |
2,065,106
-139,600
| -6% | -$86.2M |
|
31
Qualcomm
QCOM
$176B
| $1.32B | 0.91% |
7,219,129
-1,499,920
| -17% | -$240M |
|
32
Amazon
AMZN
$2.96T
| $1.31B | 0.91% |
7,846,100
-106,600
| -1% | -$18.2M |
|
33
Ross Stores
ROST
$81.9B
| $1.29B | 0.89% |
11,286,899
-161,770
| -1% | -$18.1M |
|
34
Whirlpool
WHR
$2.82B
| $1.18B | 0.81% |
5,009,775
-63,820
| -1% | -$14M |
|
35
NVIDIA
NVDA
$5.42T
| $1.13B | 0.78% |
38,460,900
-7,515,850
| -16% | -$207M |
|
36
United Airlines
UAL
$42.1B
| $1.11B | 0.77% |
25,375,838
-968,295
| -4% | -$44.9M |
|
37
Ericsson
ERIC
$33.3B
| $1.1B | 0.76% |
101,196,127
-4,380,120
| -4% | -$47.9M |
|
38
BioNTech
BNTX
$23.5B
| $1.08B | 0.75% |
4,187,118
-96,240
| -2% | -$26.4M |
|
39
TJX Companies
TJX
$178B
| $1.08B | 0.75% |
14,204,848
-273,700
| -2% | -$19M |
|
40
Raymond James Financial
RJF
$34B
| $1.03B | 0.71% |
10,264,364
+279,622
| +3% | +$27.6M |
|
41
Flex
FLEX
$44.8B
| $1.01B | 0.7% |
73,010,810
-3,133,047
| -4% | -$42.4M |
|
|
ONC
42
BeOne Medicines Ltd
ONC
$39.4B
| $1.01B | 0.7% |
3,717,507
-93,840
| -2% | -$31.7M |
|
43
Mattel
MAT
$4.23B
| $983M | 0.68% |
45,587,519
-684,220
| -1% | -$14.4M |
|
|
MRSH
44
Marsh
MRSH
$91.5B
| $974M | 0.67% |
5,601,471
-531,075
| -9% | -$88.2M |
|
45
HP
HPQ
$27.5B
| $958M | 0.66% |
25,424,525
-804,860
| -3% | -$26.3M |
|
46
Jacobs Solutions
J
$17B
| $936M | 0.65% |
8,130,592
-207,132
| -2% | -$23.9M |
|
47
Hewlett Packard
HPE
$70.5B
| $889M | 0.62% |
56,384,271
-707,590
| -1% | -$10.7M |
|
48
CarMax
KMX
$8.26B
| $889M | 0.62% |
6,827,663
-551,114
| -7% | -$77.2M |
|
|
SPLK
49
DELISTED
Splunk Inc
SPLK
| $876M | 0.61% |
7,569,051
+68,390
| +0.9% | +$9.55M |
|
|
PXD
50
DELISTED
Pioneer Natural Resource Co.
PXD
| $872M | 0.6% |
4,791,846
-38,450
| -0.8% | -$7.08M |
|
Similar funds
VAM
Primecap Management's Q4 2021 Portfolio in Review
As of Q4 2021, Primecap Management held 347 positions worth $144B, up 2% from $142B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management withdrew a net $5.9B in Q4 2021, closing 5 positions and reducing 237 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $10M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in Aurora worth $116M.
- Primecap Management's largest Q4 2021 buy was Aurora: 10,279,870 shares worth $116M.
- Primecap Management added most to Bristol-Myers Squibb in Q4 2021, an estimated $187M increase.
- Primecap Management's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $763M.
- Primecap Management fully exited Vonage Holdings Corporation in Q4 2021, selling an estimated $10M.
- Primecap Management's ten largest holdings make up 30% of its $144B portfolio in Q4 2021.
- Primecap Management opened 10 new positions and closed 5 in Q4 2021.
- Primecap Management's portfolio value rose 2% quarter-over-quarter to $144B.
Based on Primecap Management's 13F filing for Q4 2021, filed 11 Feb 2022.